|
SLC7A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.648800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.008800E-01 |
| Normal-vs-Stage2 |
4.708600E-01 |
| Normal-vs-Stage3 |
1.404640E-01 |
| Normal-vs-Stage4 |
5.400400E-02 |
| Stage1-vs-Stage2 |
3.911000E-01 |
| Stage1-vs-Stage3 |
1.294430E-01 |
| Stage1-vs-Stage4 |
5.631600E-02 |
| Stage2-vs-Stage3 |
6.090400E-01 |
| Stage2-vs-Stage4 |
3.726800E-01 |
| Stage3-vs-Stage4 |
7.419400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.798200E-02 |
| Normal-vs-AfricanAmerican |
1.937010E-01 |
| Normal-vs-Asian |
4.846600E-01 |
| Caucasian-vs-AfricanAmerican |
8.539900E-02 |
| Caucasian-vs-Asian |
3.966200E-01 |
| AfricanAmerican-vs-Asian |
8.423000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.564200E-01 |
| Normal-vs-Female |
8.265400E-01 |
| Male-vs-Female |
6.420600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.168600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.811800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.788800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.275160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.097600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.424400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.743200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.264000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.872600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.546400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.640400E-01 |
| Normal-vs-Grade 2 |
7.348600E-01 |
| Normal-vs-Grade 3 |
3.104300E-02 |
| Normal-vs-Grade 4 |
7.430600E-01 |
| Grade 1-vs-Grade 2 |
9.852800E-01 |
| Grade 1-vs-Grade 3 |
4.168000E-01 |
| Grade 1-vs-Grade 4 |
7.584600E-01 |
| Grade 2-vs-Grade 3 |
4.413800E-02 |
| Grade 2-vs-Grade 4 |
5.845600E-01 |
| Grade 3-vs-Grade 4 |
2.910600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.783100E-04 |
| Normal-vs-ccB subtype |
7.245800E-02 |
| ccA subtype-vs-ccB subtype |
1.807890E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.656500E-02 |
| Normal-vs-N1 |
7.558600E-01 |
| N0-vs-N1 |
4.118400E-01 |
|
|
